Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company out of Cranbury, New Jersey. They specialize in helping those with specific diseases. These diseases are known as rare and orphan diseases due to fact that they affect such a small portion of the population. They particularly focus on lysosomal storage disorders, which are a group of rare metabolic disorders. They had no marketed products as of February of 2014, however were taking an in-depth look at Migalastat, a product that could help treat Fabry disease. View the market summary of Amicus Therapeutics at marketwatch.com.

The company extended its site locations in 2008, locating another building in San Diego. They received a $500,000-dollar grant from The Michael J. Fox Foundation in 2010, which was intended to support their studies in medicine. In the same year, they were given yet another grant from the Alzheimer’s Drug Discovery Foundation of $210,300. The grant was made out to help Amicus Therapeutics with their pre-clinical work. This company is very dedicated to the work that they do. They aim to help those people suffering from rare diseases of which have not been cured at this point in time.

View: https://finance.yahoo.com/quote/FOLD?ltr=1

Amicus Therapeutics has done something that many other companies have not, in that they have taken on the challenge of solving rare diseases. While battling to find advancements, they have kept relationships with patients are their families at the top priority. Numerous patients had amazing things to say about the company, and how it helped them change their lives. The team members are very persistent in the work they do, and they work hard to find ways to make change. Amicus Therapeutics has a belief statement in which they live by, sort of like their motto. They have listed a number of sayings that they have pledged to stay true to. A few of the sayings include, “We encourage and embrace constant innovation” and “We encourage and embrace constant innovation”. All in all, Amicus Therapeutics has a vision to make an impact in this world, and they work hard to achieve that. Visit Google Finance to know more about Amicus Therapeutics.

Jennifer Walden, Showcasing Profound Performance in the Healthcare Industry through Cosmetic Surgery

Dr. Jennifer Walden is no strange name in the healthcare sector. She has dedicated her practice to cosmetic surgery and has a secured a position in the most coveted American Society for Aesthetic Plastic Surgery (ASAPS) among the Board of Directors. Other than that, she is also ASAPS’ commissioner of communication. Jennifer is certified by the American Board of Plastic surgery giving her authority to freely practice her area of specialization.

Dr. Walden had her working premises located in New York but shifted recently to Austin. Being a family person, she wanted to bring her twin boys closer to their family. Walden is part of major cosmetic surgery associations which includes the America Society of Plastic Surgeon and American College of Surgeons. Rounding it up, she is the media spokesperson of ASAPS a position she previously held at the American Society of Plastic Surgeons.

Throughout her career, Dr. Jennifer has been acknowledged for Walden’s consistency and outstanding performance. She appeared among the Texas Super Doctors in 2014 and was booked for membership by the American Association of Plastic Surgeons two years later. With this coveted allocation, Jennifer had definitely hit the highest note in the plastic surgery field, says all-star academy society. This highest medium of recognition was a direct reflection of Walden’s profound contribution.

While Jennifer was still in New York, she was of service at the Lenox Hills, Manhattan Eye, Throat and Ear Hospitals. At the New York University Langone Medical Center, Walden was given the post of Clinical Instructor of Plastic Surgery. Later on, she outgrew these and moved out to start her own business. She is now the founder and owner of Walden Cosmetic Surgery Center at Westlake Medical Center. Together with her team, they are dedicated to ensuring that they reach the utmost patient safety standards.

More Info : www.crunchbase.com/person/dr-jennifer-walden#/entity

With all these accomplishments, Jennifer Walden is a respectable medic with privileges of having satellite cosmetic surgery clinics in different hospitals. Not many female names are heard in the plastic surgery area let alone being of great accomplishment. It is, therefore, a turning point for other women who are willing to succeed in the sector.

The journal Oncotarget has become a high-impact publisher of more than just Oncology research

While many researchers in the cancer field are familiar with the journal Oncotarget as a source of ground-breaking oncology research, some may not know that the journal accepts papers in other fields of biology and medicine as well. The journal boasts five sections beyond oncology which include Gerotarget/Aging, Pathology, Immunology and Microbiology, Autophagy and Cell Death, and Chromosome and more information click here. The Geotarget/Aging section of the journal publishes important research on aging and age-related disease, including topics in genetics and mechanisms of aging, signal transduction pathways, cellular senescence, pharmacological and dietary anti-aging modalities, pathology in model organisms, age-related diseases including atherosclerosis, metabolic syndrome, hypertension, Alzheimer’s and Parkinson’s and other diseases and Oncotaget’s lacrosse camp. The prestigious advisory board of the Gerotarget/Aging section includes Andrew V. Schally a Nobel Prize Laureate researcher from the Veterans Affairs Medical Center Miami, FL, USA. The journal’s Pathology section was established by Michael Lisanti, the former Editor-in-Chief of the American Journal of Pathology (AJP), to extend the option of publishing in the high impact Oncotarget journal to pathology researchers. The Immunology and Microbiology section extends the journal’s focus to include papers focused on innate and adaptive immunity, immune cell development, antigen recognition and responses, inflammation, cytokines, signal transduction, gene regulation, cell proliferation, autoimmunity, infectious disease, microbiology, allergy, methods and more and Oncotarget on Facebook. The Autophagy and Cell Death section of Oncotarget led by chief editor Lorenzo Galluzzi, Ph.D. from the Université Paris Descartes/Paris V publishes papers of outstanding impact and novelty in areas of basic and translational research covering a variety of topics including: Accidental Cell Death, AMPK signaling, Apoptosis, Apoptosome, Bioenergetic Metabolism, Caspases, Death Receptors, Dependence Receptors, ER stress, HSP proteins, Lysosomal Degradation, Lysosomal Membrane Permeabilization, Necrosome Signaling, and others and www.scijournal.org/impact-factor-of-ONCOTARGET.shtml. The fifth section of Oncotarget is the Chromosome section which features quality papers on all aspects of chromosome research within the scope of Mitosis and Cytokinesis, Meiosis and Recombination, Genome Engineering, Cell Cycle and Checkpoint Controls, Comparative Genomics, Transcription, Chromosome Topology and Cohesion, Repair and Replication, Heredity and Complex Traits, Epigenomics, Computational and Modeling Approaches, Genome Stability, Aneuploidy, and Apoptosis and what Oncotarget knows.

Brian Torchin’s Career At HRCR StaffingBrian Torchin’s Career At HRCR Staffing

Brian Torchin is a medical professional who has ventured into staffing business. He first went to the University of Delaware to study exercise studies.

After that, he continued on to study a degree in pre-med in the same university. Later, he went to study chiropractic studies at the New York Chiropractic College. Learn more about Brian Torchin:  http://www.topix.com/forum/health/back-pain/TCJ48V9P77348GTUL and https://plus.google.com/106112186041036712086

After the completion of his chiropractic studies, he became licensed and a board certified chiropractic practitioner. This led him to set up his own clinic at Pennsylvania, Philadelphia. The clinic receives clients with a lot of pain and suffering. Dr. Torchin therefore has to use his medical knowledge to help them alleviate their pain.

In 2007, Dr. Torchin came up with a staffing company known as Health Care Recruitment Counselors (HCRC) staffing. This staffing company is mainly used by medical companies and legal firms. The main goal of the company is to get the best candidate for the job through ensuring that the jobs are well advertised for.

For instance, the company advertises for the different positions through social media platforms and other ways too. Wellness Magazine revealed that if you look at Brian Torchin’s Facebook and LinkedIn pages, one will realize that most of the posts are related with the staffing company.

Today, over two hundred companies in the United States of America, Australia, Canada and even Europe. Through HCRC, the medical field has even had a better turnover than it had before. Moreover, the fact that the company assures their clients that they will get what they want in a period less than seventy two hours makes it a better staffing company.

The company provides dentists, nurses, physical therapists and even cares givers. Other positions include receptionists and office managers. In legal firms, the company provides them with paralegals, attorney, secretaries and even administrators.

The company has over time learnt how to provide their clients with flexible staffing positions that are made available through the trust, respect and consistency gained.

In addition to this, the company provides specialized career consultation to their clients so that they know their options well. Other services that they offer include assessing the current market and interviewing potential employees for their clients.